Synthesis, cytotoxicity against cancer and normal cell lines of novel hydrazide–hydrazone derivatives bearing 5H-chromen-5-one

  • Rafat M. MoharebEmail author
  • Karam A. EL-Sharkawy
  • Fatma Omar Al Farouk
Original Research


The reaction of cyclohexan-1,3-dione with either of malononitrile or ethyl cyanoacetate gave the 4-amino-6,7-dihydro-5H-chromen-5-one derivatives 3a and 3b, respectively. The reaction of the latter compounds with cyanoacetylhydrazine gave the hydrazide–hydrazone derivatives 5a and 5b, respectively. Compounds 5a,b were used as the key starting materials for the synthesis of thiophen, coumarin, and pyridine derivatives. The newly synthesized compounds were evaluated against three human cancer cell lines, including HCT116 (colon carcinoma cell), MGC803 (gastric carcinoma cell), and Huh7 (hepatoma carcinoma cell). The results showed that 3b, 5b, 6b, 6d, 8b, 8c, 8d, 8f, 10b. 12a–h, 14a–d, 15a–h, and 16b–h displayed higher cytotoxic activity than 5-FU against HCT116 and MGC803 cell lines. Compounds 14d and 16f were the most promising compounds with IC50’s 0.25 and 0.09 μM against HCT116 cell line. The most potent compounds were selected for the in vitro against peripheral blood lymphocytes (PBL) from healthy donors. All compounds were practically devoid of significant cytotoxic activity in quiescent lymphocytes, with GI50’s of 42–68 μM, while with the mitogenic stimulus phytohaemagglutinin (PHA), the GI50’s were reduced to about 20–32 μM.


Cyclohexan-1,3-dione Chromen Hydrazide–hydrazone Cytotoxicity Cancer cell lines Normal cells 



The author would like to thank the Alexander von Humboldt Foundation in Bonn, Germany for affording a combined project between Prof. Klapötke and RMM through which this work was completely financed and completed.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Abadi AH, Eissa AAH, Hassan GS (2003) Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents. Chem Pharm Bull 51(2003):838–844CrossRefGoogle Scholar
  2. Bedia KK, Elçin O, Seda U, Fatma K, Nathaly S, Sevim R, Dimoglo A (2006) Synthesis and characterization of novel hydrazide-hydrazones and the study of their structure-antituberculosis activity. Eur J Med Chem 41:1253–1261CrossRefGoogle Scholar
  3. Bernardino AMR, Gomes AO, Charret KS, Freitas ACC, Machado GMC, Canto-Cavalheiro MM, Leon LL, Amaral VF (2006) Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N′-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides. Eur J Med Chem 41:80–87CrossRefGoogle Scholar
  4. Cunha AC, Figueiredo JM, Tributino JLM, Miranda ALP, Castro HC, Zingali RB, Fraga CAM, de Souza MCBV, Ferreira VF, Barreiro EJ (2003) Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives. Bioorg Med Chem 11:2051–2059CrossRefGoogle Scholar
  5. Galić N, Perić B, Kojić-Prodić B, Cimerman Z (2001) Structural and spectroscopic characteristics of aroylhydrazones derived from nicotinic acid hydrazide. J Mol Struct 559:187–194CrossRefGoogle Scholar
  6. Kaynak FB, Oztürk D, Ozbey S, Capan G (2005) New N′-alkylidene/cycloalkylidene derivatives of 5-methyl-3-phenyl-1H-indole-2-carbohydrazide: synthesis, crystal structure, and quantum mechanical calculations. J Mol Struct 740:213–221CrossRefGoogle Scholar
  7. Küçükgüzel SG, Mazi A, Sahin F, Oztürk S (2003) Stables, synthesis and biological activities of diflunisal hydrazide-hydrazones. J Eur J Med Chem 38:1005–1013CrossRefGoogle Scholar
  8. Kumar D, Kumar NM, Ghosh S, Shah K (2012) Novel bis(indolyl)hydrazide–hydrazones as potent cytotoxic agents. Bioorg Med Chem Lett 22:212–215CrossRefGoogle Scholar
  9. Leite LFCC, Ramos MN, Da Silva JBP, Miranda ALP, Fraga CAM, Barreiro EJ (1999) Synthesis and analgesic profile of novel N-containing heterocycle derivatives: arylidene 3-phenyl-1,2,4-oxadiazole-5-carbohydrazide. IlFarmaco 54:747–757CrossRefGoogle Scholar
  10. Lima PC, Lima LM, Da Silva KCM, Léda PHO, Miranda ALP, Fraga CAM, Barreiro EJ (2000) Synthesis and analgesic activity of novel N-acylarylhydrazones and isosters, derived from natural safrole. Eur J Med Chem 35:187–203CrossRefGoogle Scholar
  11. Loncle C, Brunel JM, Vidal N, Dherbomez M, Letourneux Y (2004) Synthesis and antifungal activity of cholesterol-hydrazone derivatives. Eur J Med Chem 39:1067–1071CrossRefGoogle Scholar
  12. Melnyk P, Leroux V, Sergheraert C, Grellier P (2006) Design, synthesis and in vitro antimalarial activity of an acylhydrazone library. Bioorg Med Chem Lett 16:31–35CrossRefGoogle Scholar
  13. Mohareb RM, Samir EM, Halim PA (2019) Synthesis, and anti-proliferative, Pim-1 kinase inhibitors and molecular docking of thiophenes derived from estrone. Bioorg Chem 83:402–413CrossRefGoogle Scholar
  14. Mohareb RM, Abdallah AEM, Mohamed AA (2018a) Synthesis of novel thiophene, thiazole and coumarin derivatives based on benzimidazole nucleus and their cytotoxicity and toxicity evaluations. Chem Pharm Bull 66:309–318CrossRefGoogle Scholar
  15. Mohareb RM, Abdallah AM, Ahmed EA (2017) Synthesis and cytotoxicity evaluation of thiazole derivatives obtained from 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile. Acta Pharm 67:495–510CrossRefGoogle Scholar
  16. Mohareb RM, Al-Omran F, Ibrahim RA (2018) The uses of cyclohexan-1,4-dione for the synthesis of thiophene derivatives as new anti-proliferative, prostate anticancer, c-Met and tyrosine kinase inhibitors. Med Chem Res 27:618–633Google Scholar
  17. Mohareb RM, Abdo MY, Mohamed AA (2016) Cytotoxicity and anti-proliferative properties of heterocyclic compounds derived from progesterone. Anti-Cancer Agents Med Chem 16:1043–1054CrossRefGoogle Scholar
  18. Nerkar AG, Saxena AK, Ghone SA, Thaker AK (2009) In silico screening, synthesis and in vitro evaluation of some quinazolinone and pyridine derivatives as dihydrofolate reductase inhibitors for anticancer activity. E-J Chem 6:S97–S102CrossRefGoogle Scholar
  19. Popiołek Ł, Biernasiuk A (2017) Synthesis and investigation of antimicrobial activities of nitrofurazone analogues containing hydrazide-hydrazone moiety. Saudi Pharm 25:1097–1102CrossRefGoogle Scholar
  20. Rostom SAF, Shalaby MA, El-Demellawy MA (2003) Polysubstituted pyrazoles, part 5.1 Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. a novel class of potential antitumor and anti-HCV agents. Eur J Med Chem 38:959–974CrossRefGoogle Scholar
  21. Terzioglu N, Gürsoy A (2003) Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide. Eur J Med Chem 38:781–786CrossRefGoogle Scholar
  22. Todeschini AR, Miranda ALP, Silva KCM, Parrini SC, Barreiro EJ (1998) Synthesis and evaluation of analgesic, antiinflammatory and antiplatelet properties of new 2-pyridylarylhydrazone derivatives. Eur J Med Chem 33:189–199CrossRefGoogle Scholar
  23. Üstündağ GH, Şatana D, Özhan G, Çapan G (2016) Indole-based hydrazide-hydrazones and 4-thiazolidinones: synthesis and evaluation as antitubercular and anticancer agents. J Enzym Inhib Med Chem 31:369–380Google Scholar
  24. Vicini P, Incerti M, Doytchinova IA, La Colla P, Busonera B, Loddo R (2006) Synthesis and antiproliferative activity of benzo[d]isothiazole hydrazones. Eur J Med Chem 41:624–632CrossRefGoogle Scholar
  25. Xia Y, Fan CD, Zhao BX, Zhao J, Shin DS, Miao JY (2008) Synthesis and structure–activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Eur J Med Chem 43:2347–2353CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Rafat M. Mohareb
    • 1
    Email author
  • Karam A. EL-Sharkawy
    • 2
  • Fatma Omar Al Farouk
    • 3
  1. 1.Department of Chemistry, Faculty of ScienceCairo UniversityGizaEgypt
  2. 2.Department of Pharmaceutical Chemistry, College of pharmacyJazan UniversityJazanSaudi Arabia
  3. 3.Department of Pharmaceutical Organic Chemistry, College of PharmacyHeliopolis UniversityHeliopolisEgypt

Personalised recommendations